New legal opinion: New GMOs deregulation proposal shifts safety testing, liability to EU food industry
By GMWatch Staff,
GMWatch
| 01. 14. 2025
Photo by Markus Winkler on Unsplash
The planned deregulation of new GMOs (new genomic techniques, NGTs) in the EU would shift safety testing and liability risks for plants produced with NGTs and the products derived from them, from biotech companies to the food industry. These consequences, until now unnoticed, of the EU Commission's plans to deregulate new GMOs are highlighted in a new legal opinion by the Berlin law firm GGSC on behalf of ENGA’s member VLOG (German Association for Food without Genetic Engineering). ENGA is the voice of the Non-GMO food and feed sector at the EU level.
EU Commission’s plans to deregulate new GMOs are to the detriment of the EU food sector
Heike Moldenhauer, Secretary General of ENGA, said: “With its plans to deregulate New GMOs, the European Commission is throwing the EU’s food sector ‘to the wolves’, by shifting the costs and risks from biotech to the food sector. This is unacceptable and may become a major problem for the entire EU food industry, not just the organic and ‘Non-GMO’ sectors.”
Biotechnology companies must take responsibility...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
